All
Sharing Experiences to Empower Other Patients With Breast Cancer
In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to discuss supporting others with breast cancer.
CAR-T Cell Therapy Receives FDA Designation in Kidney Cancer Subset
Regenerative Medicine Advanced Therapy designation was granted to an investigational CAR-T cell therapy for some patients with renal cell carcinoma.
The Never-Ending Cycle of Cancer: Treatment Versus Long-Term Health
My daughter faced the difficult decision of balancing the potential benefits and risks of cancer treatment, including the long-term heart complications associated with Herceptin.
Current Treatment May Be Superior to Recentin In Ovarian Cancer
Treatment containing Recentin demonstrated clinical benefits, but it proves worse than the current standard care treatment.
Balancing Decisions Around Breast Cancer Treatment and Fertility, Breastfeeding
An expert discussed how patients with breast cancer, particularly those with a BRCA mutation, should consider future fertility and breastfeeding when making treatment decisions.
First Patients Dosed in Phase 2 Trial of Ropidoxuridine for Glioblastoma
A phase 2 clinical trial of a new brain cancer treatment is underway.
FDA Approves Scemblix for Some With Newly Diagnosed Chronic Myeloid Leukemia
Treatment with Scemblix was shown to improve response rates in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.
Prostate Cancer Questions Answered, From PSA Levels to Treatment Decisions
An expert answers prostate cancer questions from a recent CURE Educated Patient Summit.
FDA Expands Approval for Jylamvo to Children With Acute Lymphoblastic Leukemia
Jylamvo is an oral liquid formulation of methotrexate originally approved in 2022 for adults with acute lymphoblastic leukemia, among other diseases.
Patients With Cancer Can Benefit from Palliative Care Earlier
An expert told CURE that patients with cancer should discuss palliative care options with their team “as early as possible.”
Phase 3 Trial Begins in mRNA-Based Therapy Plus Keytruda in Non-Small Cell Lung Cancer
This trial will assess an individualized neoantigen therapy plus Keytruda in some patients with non-small cell lung cancer.
Stivarga Improves Survival in Refractory Advanced Gastric Cancer
Stivarga improved survival and delayed disease progression in patients with refractory advanced gastric and esophagogastric junction cancer.
My Family’s Strong Support During My Experience With Colon Cancer
Carla Deschamps shares her experience with colon cancer and how her brother, sisters and parents helped her through the journey.
Radiation May Cause Secondary Cancer in Some Breast Cancers
Receiving radiation therapy for breast cancers harboring TP53 germline variants may cause secondary cancers, but risk estimates are unconfirmed.
Monitoring Treatment With Different Types of Biopsies in Lung Cancer
An expert discussed how liquid and tissue biopsies can help monitor treatment and detect potential resistance in patients with non-small cell lung cancer.
A Compassionate and Collaborative Oncology Infusion Nurse
Two colleagues of an oncology nurse highlight her utmost respect for patients and as a liaison to the greater team.
God Helped Me See a Better Side During Kidney Cancer
When I was diagnosed with a rare and aggressive kidney cancer, I turned to God and He has helped me through my journey, each step of the way.
Regular Check-Ups Provide Necessary Support During Breast Cancer Survivorship
Through regular follow-ups and symptom assessments, breast cancer survivors have the access to physical and emotional support they may need.
FDA Accepts New Drug Application for Pixclara for Glioma Imaging
The FDA has accepted a new drug application for the glioma-imaging agent Pixclara, with a decision expected next year.
Aerobic Exercise May Reduce Depression Among Patients with Cancer
Researchers have found that engaging in aerobic physical activity results in modest depression reduction among some patients with cancer.
Lessening My Apprehension Using Meditation During Lung Cancer
During my lung cancer journey, I learned a few important ways to help me lessen the apprehension I felt, including meditation.
Jenna Fischer Shares Breast Cancer Details, Los Angeles Dodgers Broadcaster in Remission and More
From “The Office” star opening up in a new interview to Charley Steiner revealing his multiple myeloma journey, here is this week’s cancer news.
Eating During Treatment Maintains Swallowing in Head and Neck Cancers
Patients undergoing transoral robotic surgery or radiation for oropharyngeal cancer should try to eat during treatment to maintain swallowing muscles.
Discussing Radiation as a Treatment Option for Kidney Cancer
An expert explained the advantages and disadvantages of radiation as a treatment for patients with renal cell carcinoma, a type of kidney cancer.
Trodelvy Is Effective in Real-World Patients With Breast Cancer Subset
Trodelvy shows effectiveness in real-world breast cancer treatment, even after receiving Enhertu therapy.
4 Things I Had to Unlearn from My Mesothelioma Journey
There are so many things that needed to be unlearned after I was diagnosed with mesothelioma, but there are ways to help with that.
Chemo vs HMAs and Venclexta Show Similar Survival Outcomes in AML
Adjusted survival outcomes were similar for patients with NPM1-mutated AML with intensive induction chemotherapy or hypomethylating agents and Venclexta.
Tranexamic Acid During Radical Cystectomy Does Not Lead to Blood Transfusion Reduction in Bladder Cancer
The use of prophylactic tranexamic acid didn't lead to a reduction in blood transfusion for patients undergoing open radical cystectomy for bladder cancer.
ONCT-534 Produces Tolerable Safety Outcomes in Relapsed/Refractory mCRPC
Meta: ONCT-534 had a well-tolerated safety profile on a twice daily dosing schedule in relapsed/refractory metastatic castration-resistant prostate cancer.
Keytruda Plus Radiation Therapy Shows Promise for Patients with Breast Cancer
Patients with TNBC and HR+/HER2- breast cancer demonstrated safe treatment with preoperative radiation therapy with Keytruda.
